LGNDLigand Pharmaceuticals IncorporatedUptrendEarnings in 2 days
TodayUptrendnormal stock
308.30+1.57% todayClose of Oct 26, 2026 · end-of-day snapshot
Not sure what's inside? Read a full TSLA analysis, currently free
Technical readingsFree
RangeboundSee the full setup read: unlock LGND
Trend state Uptrend, stage 2 of 4, no damage flags raised (as of Oct 26, 2026)
Automated read
The moving-average structure shows no decisive trend in either direction: the mid-term picture reads as rangebound. RSI is currently 55.
Readings, end-of-day Oct 26, 2026
RSI (14)Upper-neutral55.48, favorable reading
MACD / signalAbove signal line3.16 / 2.87, favorable reading
SMA 50Price above294.13, favorable reading
SMA 200Price above250.30, favorable reading
EMA 20Price above302.22, favorable reading
ADX (14)Rangebound14.05
Show all 12 readings
+DI / −DI+DI leading21.11 / 15.78
ATR (14)3.6% of price — typical daily swing10.95
Stochastic %KMid-range73.98
Bollinger bands (20)Inside bands290.28 – 316.13
ROC (10)Negative over 10 sessions-0.91, caution reading
Trend / momentum impulseTrend and momentum agreeBoth rising, favorable impulse reading
Full analysis
What unlocking LGND reveals
Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock
Generated on unlock: written when LGND's analysis runs, rather than checked against its stored data now.
Every section above, argued on LGND's own numbers, on one page.
See what LGND costsNot sure what's inside? Read a full TSLA analysis, currently freeUnlock the full LGND analysis
AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.
- Unlocked in about 60 seconds
- No account needed
- Secure checkout via Stripe
Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.
Free weekly sample report
Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.
Need the raw data?Get LGND + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset Earnings
When does Ligand Pharmaceuticals Incorporated report earnings?
Ligand Pharmaceuticals Incorporated (LGND) is scheduled to report earnings on Oct 29, 2026.
The date is confirmed rather than estimated, though companies do occasionally reschedule.
Data as of Oct 27, 2026
See who else reports soon$9.90one-time Unlock LGND